Chemical, molecular, and single cell analysis reveal chondroitin sulfate proteoglycan aberrancy in fibrolamellar carcinoma
A. Francisco, J. Li, A. Farghli, M. Kanke, B. Shui, P. Soloway, Z. Wang, L. Reid, J. Liu, P. Sethupathy
This study identifies increased chondroitin sulfate proteoglycan levels in fibrolamellar carcinoma through gene expression, mass spectrometry, and single-cell sequencing.
bioRxiv · Dec 7, 2021 · PreprintCancer Biology